Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-11-16 / Int. J. Oncol. 2012 Mar;40(3):840-50Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo
/in International Publications, Newcastle Disease Virus, NSCLC /von 2011-11-15 / Cancer Lett. 2012 Apr;317(1):56-64Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-11-07 / World Neurosurg 2012 May-Jun;77(5-6):736-44Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients
/in Dendritic Cells, International Publications /von 2011-11-02 / J. Immunol. 2011 Dec;187(11):6130-42Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy
/in Colorectal Cancer, Hyperthermia, International Publications /von 2011-11-01 / Anticancer Res. 2011 Nov;31(11):3963-7Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2011-11-01 / Anticancer Res. 2011 Nov;31(11):3995-4005Safety and clinical usage of newcastle disease virus in cancer therapy
/in International Publications, Newcastle Disease Virus /von 2011-10-26 / J. Biomed. Biotechnol. 2011;2011:718710Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2011-10-22 / Cancer Immunol. Immunother. 2012 May;61(5):629-41Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
/in Breast Cancer, Dendritic Cells, Hypernephroma, International Publications /von 2011-10-20 / J Transl Med 2011 Oct;9:178IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de